Inhibition of interleukin-3-dependent growth of CD34+ acute myelogenous leukemia cells by recombinant soluble CD23

Ann N Y Acad Sci. 1991:628:362-7. doi: 10.1111/j.1749-6632.1991.tb17269.x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal
  • Antigens, CD / analysis*
  • Antigens, CD / physiology*
  • Antigens, CD34
  • Antigens, Differentiation, B-Lymphocyte / physiology*
  • Bone Marrow / pathology*
  • Cell Division / drug effects
  • HLA Antigens / analysis
  • Hematopoietic Stem Cells / drug effects
  • Hematopoietic Stem Cells / pathology*
  • Humans
  • In Vitro Techniques
  • Interleukin-1 / pharmacology
  • Interleukin-3 / pharmacology*
  • Leukemia, Myeloid, Acute / immunology
  • Leukemia, Myeloid, Acute / pathology*
  • Phenotype
  • Receptors, Fc / physiology*
  • Receptors, IgE
  • Recombinant Proteins / pharmacology

Substances

  • Antibodies, Monoclonal
  • Antigens, CD
  • Antigens, CD34
  • Antigens, Differentiation, B-Lymphocyte
  • HLA Antigens
  • Interleukin-1
  • Interleukin-3
  • Receptors, Fc
  • Receptors, IgE
  • Recombinant Proteins